Question: I'm looking for a contract research organization that can accelerate drug discovery and development for various diseases.

If you need a contract research organization (CRO) to speed up drug discovery and development for a range of diseases, ChemDiv is a good option. The company, which has more than 30 years of experience, uses Hybrid Artificial Intelligence (AI) and Machine Learning (ML) to offer a range of services including target ID, syntheses and clinical trials. Its compound library and integrated services can help streamline the drug discovery process, so you can focus on innovation and getting new treatments to market.

Another option is Insilico Medicine, which uses AI to accelerate pharmaceutical research and development. Its platform includes tools for target identification, molecule design and clinical trial outcome prediction, shortening the time and cost of traditional methods. PHARMA.AI, PandaOmics, Chemistry42 and inClinico are some of the products that can help speed your project.

If you're interested in AI-powered information retrieval, BenchSci has the ASCEND platform. It's designed to speed up drug discovery by giving you access to a large database and multimodal AI that can understand experiments. It includes generative AI for summarization and conversational AI to guide experiment decisions, and it's useful for pharmaceutical and biotech R&D labs.

Last, Atomwise offers an AI-based drug discovery platform using convolutional neural networks and large chemical libraries. It's good at handling poorly annotated targets and traversing large chemical space, so it can be good for finding new small molecule medicines. Its focus on scalability and continuous training means it's good for large-scale and high-speed drug discovery.